Strategic partnerships Mawi has recent collaboration activity with Helix, GenoBank.io, and Solena Ag, signaling openness to channel and technology partnerships. This presents opportunities to position complementary sample collection, storage, or data interoperability solutions to established genomics and biotech platforms.

Expand non-invasive workflows The company specializes in non-invasive and invasive biosample collection with room temperature transport, targeting genomics, proteomics, and metabolomics. Sales conversations can emphasize scalable, user-friendly collection kits for clinical, research, and at-home sampling programs to broaden access and adherence.

BioNFT and tokenization Recent collaboration with GenoBank.io to tokenize iSWAB systems as BioNFTs indicates appetite for digital asset strategies and traceability. This opens doors for partnerships around provenance, asset tracking, and compliant data monetization for biobanks and research networks.

Soil and environmental applications Integration with Solena Ag’s Prometheus platform suggests demand in soil health and environmental biosamples. This creates sales angles for environmental monitoring, agriculture tech customers, and ecosystem health studies leveraging stable sample collection in varied conditions.

Growth and funding signals Revenue range and recognition of innovation awards, plus leadership hires and board additions, point to a growing, credible player in biosample technology. Upsell opportunities exist with mid-market labs and CROs seeking robust, scalable sample collection solutions and global sample integrity.